Gilead Sciences ($GILD) Insider Trading & Smart Money Activity

Gilead Sciences, Inc. · Drug Manufacturers - General · Latest filing Oct 16, 2026

Gilead Sciences, Inc. ($GILD) has 5 insider trades, 3 congress trades, 27 13F position changes and 5 analyst ratings on file. In the last 12 months on the open market, no insider bought and 4 insiders sold ($3.90M), net -$3.90M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
4
Net insider $ (12 mo)
-$3.90M
Congress trades (12 mo)
2
13F moves on file
27
Analyst ratings on file
5

GILD insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 1 / 0 1 / 0
Q2 2026 0 2 · $747.97K 1 / 0 9 / 13
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 3 · $3.16M 0 / 0 2 / 2

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All GILD insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F ASR Vermogensbeheer N.V. Reduced -69.90K sh $15.52M —
13F ARS Wealth Advisors Group New +1.46K sh $217.28K Read
Insider Johanna MercierChief Comm & Corp Aff Officer Sell (Open-market sale) 10b5-1 3K sh $468.66K -2.57% SEC Read
Insider Andrew D DickinsonChief Financial Officer Sell (Open-market sale) 10b5-1 3K sh $468.66K -1.83% SEC Read
13F Fjarde Ap-Fonden /Fourth Swedish National Pension Fund Reduced -110.01K sh $83.27M —
13F Moody Lynn Lieberson & Walker Added +18.04K sh $18.42M —
Analyst Cantor Fitzgerald Reiterates to Overweight PT $155 +7.0% —
Analyst Truist Securities Reiterates to Buy PT $158 +4.6% —
Analyst Morgan Stanley Reiterates to Overweight PT $163 +4.6% —
Analyst JP Morgan Reiterates to Overweight PT $170 +4.6% —
Insider O'Day Daniel PatrickChairman & CEO Sell (Open-market sale) 10b5-1 15K sh $2.22M -0.3% —
Analyst Cantor Fitzgerald Reiterates to buy PT $155 -1.7%+7.1% Read
Insider Johanna MercierChief Comm & Corp Aff Officer Sell (Open-market sale) 10b5-1 3K sh $371.77K +0.5%+6.0% Read
Insider Andrew DickinsonChief Financial Officer Sell (Open-market sale) 10b5-1 3K sh $376.20K +0.5%+6.0% Read
13F Holocene Advisors Reduced -1.55M sh $329.98M +3.7%-3.4% —
13F Zacks Investment Management Reduced -12.27K sh $67.69M -1.2%-5.3% —
13F Massachusetts Financial Services Added +2.06M sh $799.21M -1.2%-5.3% Read
13F Lord, Abbett Added +791.14K sh $252.72M -1.2%-5.3% —
13F Dodge & Cox Reduced -2.03M sh $3.06B -1.2%-5.3% —
13F Dodge & Cox Reduced -2.03M sh $3.05B -1.2%-5.3% Read
13F Caisse de Depot Et Placement Du Quebec Added +594.77K sh $195.10M -1.2%-5.3% Read
13F Aviva Added +17.84K sh $148.40M -1.2%-5.3% —
13F Nordea Investment Management Added +121.66K sh $664.59M -1.8%-5.6% —
13F Korea Investment Reduced -225.91K sh $143.08M -1.8%-5.6% —
13F Capital World Investors Reduced -1.59M sh $5.22B -1.8%-5.6% —
13F Capital World Investors Reduced -1.59M sh $5.20B -1.8%-5.6% —
13F Rakuten Investment Management Added +27.29K sh $32.53M -3.3%-6.7% —
13F Great Lakes Advisors Added +67.28K sh $137.65M -3.3%-6.7% —
13F Lsv Asset Management Reduced -1.25M sh $365.44M -2.9%-9.0% —
Congress Jared Moskowitz Purchase $1,001 - $15,000 -2.4%-5.2% Read
13F California Public Employees Retirement System Reduced -116.76K sh $452.88M -2.4%-5.2% —
13F Wealthfront Advisers Added +250.91K sh $61.78M +1.1%-3.2% —
13F Calamos Advisors Added +187.02K sh $52.13M +0.6%-2.8% —
13F Sumitomo Mitsui Trust Group Reduced -337.88K sh $370.30M +2.5%+0.2% —
13F Candriam S.C.A. Reduced -163.48K sh $211.02M +2.5%+0.2% —
13F Aberdeen Group Reduced -85.42K sh $139.01M +5.8%+4.3% —
Congress Alan Armstrong Purchase $1,001 - $15,000 +4.4%-4.8%+13.8% —
Congress Tommy Tuberville Sale $1,001 - $15,000 —

Showing 38 of 40 filings (the latest 13F moves are capped at 25; see the institutions below).

1W / 1M / 6M = how GILD moved from the trade or filing date.

Insider trading in GILD: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Johanna Mercier Chief Comm & Corp Aff Officer 2 -$840.43K 113.68K Oct 15, 2026
Andrew D Dickinson Chief Financial Officer 1 -$468.66K 161.10K Oct 15, 2026
O'Day Daniel Patrick Chairman & CEO 1 -$2.22M Oct 1, 2026
Andrew Dickinson Chief Financial Officer 1 -$376.20K Jun 15, 2026

Members of Congress trading GILD

Institutions moving GILD (13F)

Analyst ratings on GILD

DateFirmActionRatingPrice target1W1M6MStory
Cantor Fitzgerald Reiterates Overweight $155 +7.0% —
Truist Securities Reiterates Buy $150 → $158 +4.6% —
Morgan Stanley Reiterates Overweight $165 → $163 +4.6% —
JP Morgan Reiterates Overweight $160 → $170 +4.6% —
Cantor Fitzgerald Reiterates buy $155 -1.7%+7.1% Read

Frequently asked questions

Are GILD insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 4 insiders made 5 open-market sales worth $3.90M, a net -$3.90M.

What is the latest insider trade in GILD?

Johanna Mercier, Chief Comm & Corp Aff Officer filed a sell (open-market sale) of 3K sh worth $468.66K on Oct 15, 2026.

Which members of Congress traded GILD?

3 disclosed trades by Jared Moskowitz, Alan Armstrong and Tommy Tuberville. The latest was on May 6, 2026.

Which institutions changed their GILD positions?

Recent 13F filers moving the stock include Dodge & Cox, Capital World Investors, ASR Vermogensbeheer N.V., ARS Wealth Advisors Group and Fjarde Ap-Fonden /Fourth Swedish National Pension Fund.

Other drug manufacturers - general stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text